What's next for Ebos after the end of that Chemist Warehouse contract

What's next for Ebos after the end of that Chemist Warehouse contract
CEO John Cullity says there isn't double-digit growth to be found in animal or healthcare in Australasia. (Image: Ebos)
Rebecca Stevenson
Ebos chief executive John Cullity says the firm must hunt outside of Australasia for double-digit growth. The dual-listed healthcare and pharmaceutical marketer and wholesaler was looking for growth outside its traditional powerhouse pharmaceutical business, Cullity said. He said Ebos’s pharmacy business in NZ and Australia was solid and stable but had relatively low growth. “Double-digit growth rates are going to be very hard, so we need to broaden the group's base of earnings outside of Australia and New Zealand...

More Markets

NZ sharemarket rises with gentailers leading
Markets Market close

NZ sharemarket rises with gentailers leading

Electricity gentailers pumped energy into the NZX.

Tom Raynel 09 May 2025
Steven Joyce to chair NZME
Markets

Steven Joyce to chair NZME

Tech expert Bowen Pan will also join, later on. 

Staff reporters 09 May 2025
NZME set to take on Trade Me for car sales
Markets

NZME set to take on Trade Me for car sales

Publicly listed NZME, owner of the NZ Herald and BusinessDesk, says it is exploring a new automotive digital classifieds platform, in a clear bid to take on Trade Me.Seeking to emulate the success of its property platform OneRoof, NZME said on Friday it had signed a memorandum of...

Staff reporters 09 May 2025
Bremworth getting back into synthetics
Primary Sector

Bremworth getting back into synthetics

Albeit in a small, but carefully curated, number of products.

Riley Kennedy 09 May 2025